PPARG and inflammatory bowel disease: Though the role for PPARγ in IBD is controversial (65), a plethora of studies suggest that PPARγ activation might impede pathophysiological imbalances associated with IBD (66).15d-PGJ2, as an endogenous PPARγ ligand, has been reported to inhibit pro-inflammatory signaling (16, 67).